Drug intelligence / Profile preview

drynaria quercifolia ethyl acetate fraction

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Drynaria quercifolia ethyl acetate fraction is a **plant-derived small-molecule phytochemical extract** prepared from the rhizome of *Drynaria quercifolia*. It has been investigated only in **preclinical academic studies** and does not appear to have a commercial sponsor, approved product name, or established pharmaceutical development program. Reported activities include **antioxidant and anticholinesterase effects** in neurobehavioral models, with amelioration of scopolamine-induced memory impairment in mice, and **antifibrotic/hepatoprotective effects** in experimental liver injury models, where the extract has been associated with modulation of **Nrf2/ARE** and **NFkB** signaling. Because this is a botanical fraction rather than a single chemically defined active ingredient, its pharmacology is best understood as a multi-component phytochemical mixture enriched in phenolics and flavonoids rather than a precisely target-selective drug.

Other names
drynaria quercifolia ethyl acetate fractionethyl acetate fraction of Drynaria quercifoliaDrynaria quercifolia ethyl acetate extract
02

Targets

AcetylcholinesteraseNFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)ButyrylcholinesteraseNF-κB

Beyond the preview

Go deeper on drynaria quercifolia ethyl acetate fraction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on drynaria quercifolia ethyl acetate fraction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call